Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 52
Titolo Data di pubblicazione Autore(i) File
Myelodysplastic syndromes 2004 CILLONI D; MESSA F; CARTURAN S; ARRUGA F; DEFILIPPI I; MESSA E; GOTTARDI E; SAGLIO G
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation 2004 CILLONI D; MESSA F; GOTTARDI E; FAVA M; ARRUGA F; DEFILIPPI I; CARTURAN S; MESSA E; MOROTTI A; GIUGLIANO E; REGE-CAMBRIN G; ALBERTI D; BACCARANI M; SAGLIO G
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients 2004 CILLONI D; CARTURAN S; GOTTARDI E; MESSA F; FAVA M; DEFILIPPI I; ARRUGA F; SAGLIO G.
WT1 overexpression: A clinically useful marker in acute and chronic myeloid leukemias 2005 SAGLIO G; CARTURAN S; GRILLO S; CAPELLA S; ARRUGA F; DEFILIPPI I; ROSSO V; RAUCO M; MARINA LIBERATI A; CILLONI D
The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance 2006 CILLONI D; MESSA F; ARRUGA F; DEFILIPPI I; MOROTTI A; MESSA E; CARTURAN S; GIUGLIANO E; PAUTASSO M; BRACCO E.; ROSSO V; SEN A; MARTINELLI G; BACCARANI M; SAGLIO G.
NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line 2006 MOROTTI A; CILLONI D; PAUTASSO M; MESSA F; ARRUGA F; DEFILIPPI I; CARTURAN S; CATALANO R; ROSSO V; CHIARENZA A; TAULLI R; BRACCO E; REGE-CAMBRIN G; GOTTARDI E; SAGLIO G
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leucemia cells 2006 MOROTTI A; CILLONI D; MESSA F; ARRUGA F; DEFILIPPI I; CARTURAN S; CATALANO; R; ROSSO V; CHIARENZA A; PILATRINO C; GUERRASIO A; TAULLI R; BRACCO E; PAUTASSO; M; BARABAN D; GOTTARDI E; SAGLIO G.
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes 2006 CILLONI D; MESSA E; MESSA F; CARTURAN S; DEFILIPPI I; ARRUGA F; ROSSO V; CATALANO R; BRACCO E; NICOLI P; SAGLIO G
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia 2007 CILLONI D; MESSA F; MARTINELLI G; GOTTARDI E; ARRUGA F; DEFILIPPI I; CARTURAN; S; MESSA E; FAVA M; GIUGLIANO E; ROSSO V; CATALANO R; MERANTE S; NICOLI P; RONDONI M; OTTAVIANI E; SOVERINI S; TIRIBELLI M; PANE F; BACCARANI M; SAGLIO G
Identification of different Ikaros cDNAtranscripts in Philadelphia-positive adult acute lymphoblastic leukemia by ahigh-throughput capillary electrophoresis sizing method 2008 Iacobucci I; Lonetti A; Cilloni D; Messa F; Ferrari A; Zuntini R; Ferrari S; Ottaviani E; Arruga F; Paolini S; Papayannidis C; Piccaluga PP; Soverini S; Saglio G; Pane F; Baruzzi A; Vignetti M; Berton G; Vitale A; Chiaretti S; Müschen M; Foà R; Baccarani M; Martinelli G.
Expression of spliced oncogenic Ikaros isoforms inPhiladelphia-positive acute lymphoblastic leukemia patients treated with tyrosinekinase inhibitors: implications for a new mechanism of resistance 2008 Iacobucci I; Lonetti A; Messa F; Cilloni D; Arruga F; Ottaviani E; Paolini S; Papayannidis C; Piccaluga PP; Giannoulia P; Soverini S; Amabile M; Poerio A; Saglio G; Pane F; Berton G; Baruzzi A; Vitale A; Chiaretti S; Perini G; Foà R; Baccarani M; Martinelli G.
Early prediction of treatment outcome in acute myeloid leukemia by measurment of WT1 transcript levels in peripheral blood samples collected after chemotherapy 2008 Cilloni D.; Messa F.; Arruga F.; Defilippi I.; Gottardi E.; Fava M.; Carturan S.; Catalano R.; Bracco E.; Messa E.; Nicoli P.; Diverio D.; Sanz MA; Martinelli G.; Lo-Coco F.; Saglio G.
Deferasiroxtreatment improved the hemoglobin level and decreased transfusion requirements infour patients with the myelodysplastic syndrome and primary myelofibrosis 2008 Messa E; Cilloni D; Messa F; Arruga F; Roetto A; Saglio G.
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis. 2010 Rosti V, Bonetti E, Bergamaschi G, Campanelli R, Guglielmelli P, Maestri M, Magrini U, Massa M, Tinelli C, Viarengo G, Villani L, Primignani M, Vannucchi AM, Frassoni F, Barosi G; AGIMM Investigators Collaborators (73) Vannucchi AM, Antonioli E, Bartalucci N, Biamonte F, Bogani C, Bosi A, Fjerza R, Guglielmelli P, Malevolti E, Pancrazzi A,Pieri L, Spolverini A, Susini MC, Tozzi L, Bortoluzzi S, Bisognin A, Coppe A, Marchioli R, Barosi G, Azzan C, Badalucco S,Balduini A, Bergamaschi G, Bonetti E, Campanelli R, Carolei A, Currao M, Isgrò MA, Lupo ML, Magrini U, Massa M, Magni V,Rosti V, Villani L, Cazzola M, Bernasconi P, Boggi S, Elena C, Gallì A, Malcovati L, Pascutto C, Passamonti F, Pietra D,Rumi E, Dejana E, Corada M, Giannotta M, Rambaldi A, Ferrari ML, Finazzi G, Finazzi MC, Magri M, Quaresmini G, Montalvo ML, Ricci C, Salmoiraghi S, Spinelli O, Amaru A, Golay J, Cilloni D, Arruga F, Bracco E, Carturan S, Gaidano V, Guerrasio A,Pradotto M, Manfredini R, Bianchi E, Montanari M, Salati S, Tagliafico E, Tenedini E, Zini R
Deferasirox is a powerful NF-kappaB inhibitor inmyelodysplastic cells and in leukemia cell lines acting independently from celliron deprivation by chelation and reactive oxygen species scavenging 2010 E. Messa;S. Carturan;C. Maffe;M. Pautasso;E. Bracco;A. Roetto;F. Messa;F. Arruga;I. Defilippi;V. Rosso;C. Zanone;A. Rotolo;E. Greco;R. M. Pellegrino;D. Alberti;G. Saglio;D. Cilloni
Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients 2010 Iacobucci I; Lonetti A; Messa F; Ferrari A; Cilloni D; Soverini S; Paoloni F; Arruga F; Ottaviani E; Chiaretti S; Messina M; Vignetti M; Papayannidis C; Vitale A; Pane F; Piccaluga PP; Paolini S; Berton G; Baruzzi A; Saglio G; Baccarani M; Foà R; Martinelli G.
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. 2012 Rossi D; Trifonov V; Fangazio M; Bruscaggin A; Rasi S; Spina V; Monti S; Vaisitti T; Arruga F; Famà R; Ciardullo C; Greco M; Cresta S; Piranda D; Holmes A; Fabbri G; Messina M; Rinaldi A; Wang J; Agostinelli C; Piccaluga PP; Lucioni M; Tabbò F; Serra R; Franceschetti S; Deambrogi C; Daniele G; Gattei V; Marasca R; Facchetti F; Arcaini L; Inghirami G; Bertoni F; Pileri SA; Deaglio S; Foà R; Dalla-Favera R; Pasqualucci L; Rabadan R; Gaidano G.
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia. 2013 Vaisitti T; Audrito V; Serra S; Bologna C; Arruga F; Brusa D; Buonincontri R; Gizdic B; Deaglio S.
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. 2014 F. Arruga; B. Gizdic; S. Serra; T. Vaisitti; C. Ciardullo; M. Coscia; L. Laurenti; G. D'Arena; O. Jaksic; G. Inghirami; D. Rossi; G. Gaidano; S. Deaglio
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 2014 Audrito, V; Serra, S; Brusa, D; Mazzola, F; Arruga, F; Vaisitti, T; Coscia, M; Maffei, R; Rossi, D; Wang, T; Inghirami, G; Rizzi, M; Gaidano, G; Wolberger, C; Raffaelli, N; Deaglio, S
Mostrati risultati da 1 a 20 di 52
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile